Report Detail
COVID-19 Impact on Global Amyotrophic Lateral Sclerosis (ALS) Market Insights, Forecast to 2026
- RnM4018038 |
- 09 June, 2020 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Amyotrophic Lateral Sclerosis (ALS) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis (ALS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Amyotrophic Lateral Sclerosis (ALS) market is segmented into
Riluzole
Edaravone (Radicava)
Other
Segment by Application, the Amyotrophic Lateral Sclerosis (ALS) market is segmented into
Hospital
Drugs Store
Other
Regional and Country-level Analysis
The Amyotrophic Lateral Sclerosis (ALS) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Amyotrophic Lateral Sclerosis (ALS) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Amyotrophic Lateral Sclerosis (ALS) Market Share Analysis
Amyotrophic Lateral Sclerosis (ALS) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Amyotrophic Lateral Sclerosis (ALS) business, the date to enter into the Amyotrophic Lateral Sclerosis (ALS) market, Amyotrophic Lateral Sclerosis (ALS) product introduction, recent developments, etc.
The major vendors covered:
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
1 Study Coverage
- 1.1 Amyotrophic Lateral Sclerosis (ALS) Product Introduction
- 1.2 Market Segments
- 1.3 Key Amyotrophic Lateral Sclerosis (ALS) Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Growth Rate by Type
- 1.4.2 Riluzole
- 1.4.3 Edaravone (Radicava)
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Drugs Store
- 1.5.4 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Amyotrophic Lateral Sclerosis (ALS) Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Amyotrophic Lateral Sclerosis (ALS) Industry
- 1.6.1.1 Amyotrophic Lateral Sclerosis (ALS) Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Amyotrophic Lateral Sclerosis (ALS) Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Amyotrophic Lateral Sclerosis (ALS) Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Amyotrophic Lateral Sclerosis (ALS) Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Estimates and Forecasts
- 2.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Revenue 2015-2026
- 2.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales 2015-2026
- 2.2 Amyotrophic Lateral Sclerosis (ALS) Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Amyotrophic Lateral Sclerosis (ALS) Competitor Landscape by Players
- 3.1 Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturers
- 3.1.1 Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturers (2015-2020)
- 3.1.2 Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Manufacturers (2015-2020)
- 3.2 Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturers
- 3.2.1 Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturers (2015-2020)
- 3.2.2 Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Amyotrophic Lateral Sclerosis (ALS) Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (ALS) Revenue in 2019
- 3.2.5 Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Amyotrophic Lateral Sclerosis (ALS) Price by Manufacturers
- 3.4 Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base Distribution, Product Types
- 3.4.1 Amyotrophic Lateral Sclerosis (ALS) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Type
- 3.4.3 Date of International Manufacturers Enter into Amyotrophic Lateral Sclerosis (ALS) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Type (2015-2020)
- 4.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2015-2020)
- 4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2015-2020)
- 4.1.3 Amyotrophic Lateral Sclerosis (ALS) Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Type (2021-2026)
- 4.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Type (2021-2026)
- 4.2.3 Amyotrophic Lateral Sclerosis (ALS) Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Application (2015-2020)
- 5.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2015-2020)
- 5.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2015-2020)
- 5.1.3 Amyotrophic Lateral Sclerosis (ALS) Price by Application (2015-2020)
- 5.2 Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Application (2021-2026)
- 5.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Amyotrophic Lateral Sclerosis (ALS) Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Amyotrophic Lateral Sclerosis (ALS) by Country
- 6.1.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country
- 6.1.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Type
- 6.3 North America Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Application
7 Europe
- 7.1 Europe Amyotrophic Lateral Sclerosis (ALS) by Country
- 7.1.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country
- 7.1.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Type
- 7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) by Region
- 8.1.1 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region
- 8.1.2 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Type
- 8.3 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Amyotrophic Lateral Sclerosis (ALS) by Country
- 9.1.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Country
- 9.1.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Type
- 9.3 Central & South America Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) by Country
- 10.1.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country
- 10.1.2 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Type
- 10.3 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Facts & Figures by Application
11 Company Profiles
- 11.1 Mitsubishi Tanabe Pharma
- 11.1.1 Mitsubishi Tanabe Pharma Corporation Information
- 11.1.2 Mitsubishi Tanabe Pharma Description, Business Overview and Total Revenue
- 11.1.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
- 11.1.5 Mitsubishi Tanabe Pharma Recent Development
- 11.2 Sanofi
- 11.2.1 Sanofi Corporation Information
- 11.2.2 Sanofi Description, Business Overview and Total Revenue
- 11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Sanofi Amyotrophic Lateral Sclerosis (ALS) Products Offered
- 11.2.5 Sanofi Recent Development
- 11.3 Mylan Pharma
- 11.3.1 Mylan Pharma Corporation Information
- 11.3.2 Mylan Pharma Description, Business Overview and Total Revenue
- 11.3.3 Mylan Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
- 11.3.5 Mylan Pharma Recent Development
- 11.4 Apotex
- 11.4.1 Apotex Corporation Information
- 11.4.2 Apotex Description, Business Overview and Total Revenue
- 11.4.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Apotex Amyotrophic Lateral Sclerosis (ALS) Products Offered
- 11.4.5 Apotex Recent Development
- 11.5 Glemark Generics
- 11.5.1 Glemark Generics Corporation Information
- 11.5.2 Glemark Generics Description, Business Overview and Total Revenue
- 11.5.3 Glemark Generics Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Products Offered
- 11.5.5 Glemark Generics Recent Development
- 11.6 Covis Pharma
- 11.6.1 Covis Pharma Corporation Information
- 11.6.2 Covis Pharma Description, Business Overview and Total Revenue
- 11.6.3 Covis Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
- 11.6.5 Covis Pharma Recent Development
- 11.7 Sun Pharma
- 11.7.1 Sun Pharma Corporation Information
- 11.7.2 Sun Pharma Description, Business Overview and Total Revenue
- 11.7.3 Sun Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
- 11.7.5 Sun Pharma Recent Development
- 11.8 Lunan Pharma
- 11.8.1 Lunan Pharma Corporation Information
- 11.8.2 Lunan Pharma Description, Business Overview and Total Revenue
- 11.8.3 Lunan Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
- 11.8.5 Lunan Pharma Recent Development
- 11.1 Mitsubishi Tanabe Pharma
- 11.1.1 Mitsubishi Tanabe Pharma Corporation Information
- 11.1.2 Mitsubishi Tanabe Pharma Description, Business Overview and Total Revenue
- 11.1.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Products Offered
- 11.1.5 Mitsubishi Tanabe Pharma Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Projections by Region
- 12.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Forecast by Regions 2021-2026
- 12.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast by Regions 2021-2026
- 12.2 North America Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast (2021-2026)
- 12.2.1 North America: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast (2021-2026)
- 12.2.2 North America: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast (2021-2026)
- 12.2.3 North America: Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Country (2021-2026)
- 12.3 Europe Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast (2021-2026)
- 12.3.1 Europe: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast (2021-2026)
- 12.3.2 Europe: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast (2021-2026)
- 12.3.3 Europe: Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast (2021-2026)
- 12.5.2 Latin America: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Amyotrophic Lateral Sclerosis (ALS) Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Amyotrophic Lateral Sclerosis (ALS) Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Amyotrophic Lateral Sclerosis (ALS) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Amyotrophic Lateral Sclerosis (ALS) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Amyotrophic Lateral Sclerosis (ALS) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Amyotrophic Lateral Sclerosis (ALS). Industry analysis & Market Report on COVID-19 Impact on Global Amyotrophic Lateral Sclerosis (ALS) is a syndicated market report, published as COVID-19 Impact on Global Amyotrophic Lateral Sclerosis (ALS) Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Amyotrophic Lateral Sclerosis (ALS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
